A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears

Journal of Immunological Methods

Volumn 353, Issue 1-2, 2010, Pages 87-92

  Orosz, Zsuzsanna Z ^a   Katona, Éva ^a   Facskó, Andrea ^a   Berta, András ^a   Muszbek, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Chemiluminescence immunoassay; Factor XIII; Factor XIII subunits; Tears

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 A2B2; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; TEAR PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; CALIBRATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; LACRIMAL FLUID; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; TEAR FLOW;

ADULT; CALIBRATION; CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XIII; FEMALE; HUMANS; MALE; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TEARS; YOUNG ADULT;

EID: 77649274566     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.01.001     Document Type: Article

References (28)

1. Berta A. Enzymology of the Tears 1992, CRC Press, Boca Raton.
2. Chung S.I., Lewis M.S., Folk J.E. Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. J. Biol. Chem. 1974, 249:940.
3. Dardik R., Solomon A., Loscalzo J., Eskaraev R., Bialik A., Goldberg I., Schiby G., Inbal A. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1472.
4. Dardik R., Loscalzo J., Eskaraev R., Inbal A. Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler. Thromb. Vasc. Biol. 2005, 25:526.
5. Dardik R., Loscalzo J., Inbal A. Factor XIII (FXIII) and angiogenesis. J. Thromb. Haemost. 2006, 4:19.
6. Dardik R., Krapp T., Rosenthal E., Loscalzo J., Inbal A. Effect of FXIII on monocyte and fibroblast function. Cell. Physiol. Biochem. 2007, 19:113.
7. Drew A.F., Kaufman A.H., Kombrinck K.W., Danton M.J., Daugherty C.C., Degen J.L., Bugge T.H. Ligneous conjunctivitis in plasminogen-deficient mice. Blood 1998, 91:1616.
8. Duckert F., Jung E., Shmerling D.H. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb. Diath. Haemorrh. 1960, 5:179.
9. Hingorani M., Metz D., Lightman S.L. Characterisation of the normal conjunctival leukocyte population. Exp. Eye Res. 1997, 64:905.
10. Inbal A., Lubetsky A., Krapp T., Castel D., Shaish A., Dickneitte G., Modis L., Muszbek L. Impaired wound healing in factor XIII deficient mice. Thromb. Haemost. 2005, 94:432.
11. Ivaskevicius V., Seitz R., Kohler H.P., Schroeder V., Muszbek L., Ariens R.A., Seifried E., Oldenburg J. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb. Haemost. 2007, 97:914.
12. Katona E., Haramura G., Karpati L., Fachet J., Muszbek L. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Thromb. Haemost. 2000, 83:268.
13. Katona E.E., Ajzner E., Toth K., Karpati L., Muszbek L. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J. Immunol. Methods 2001, 258:127.
14. Linnet K., Kondratovich M. Partly nonparametric approach for determining the limit of detection. Clin. Chem. 2004, 50:732.
15. Lorand L., Credo R.B., Janus T.J. Factor XIII (fibrin-stabilizing factor). Methods Enzymol. 1981, 80(Pt C):333.
16. Mathers W.D., Daley T.E. Tear flow and evaporation in patients with and without dry eye. Ophthalmology 1996, 103:664.
17. Mehta R., Shapiro A.D. Plasminogen deficiency. Haemophilia 2008, 14:1261.
18. Mishima S., Gasset A., Klyce S.D., Baum J.L. Determination of tear volume and tear flow. Invest. Ophthalmol. 1966, 5:264.
19. Muszbek L., Polgar J., Boda Z. Platelet factor XIII becomes active without the release of activation peptide during platelet activation. Thromb. Haemost. 1993, 69:282.
20. Muszbek L., Haramura G., Polgar J. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets. Thromb. Haemost. 1995, 73:702.
21. Muszbek L., Yee V.C., Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb. Res. 1999, 94:271.
22. Muszbek L., Bagoly Z., Bereczky Z., Katona E. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis. Cardiovasc. Hematol. Agents Med. Chem. 2008, 6:190.
23. Perrio M.J., Ewen D., Trevethick M.A., Salmon G.P., Shute J.K. Fibrin formation by wounded bronchial epithelial cell layers in vitro is essential for normal epithelial repair and independent of plasma proteins. Clin. Exp. Allergy 2007, 37:1688.
24. Polgar J., Hidasi V., Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem. J. 1990, 267:557.
25. Schuster V., Hugle B., Tefs K. Plasminogen deficiency. J. Thromb. Haemost. 2007, 5:2315.
26. Tiffany J.M. The normal tear film. Dev. Ophthalmol. 2008, 41:1.
27. Uotila M.H., Soble R.E., Savory J. Measurement of tear calcium levels. Invest. Ophthalmol. 1972, 11:258.
28. Yorifuji H., Anderson K., Lynch G.W., Van de Water L., McDonagh J. B protein of factor XIII: differentiation between free B and complexed B. Blood 1988, 72:1645.